Hikma Ventures
London, United Kingdom
23
21M
17
2.56
2
0.26
1
- Stages of investment
- Areas of investment
Summary
Hikma Ventures is the famous VC, which was founded in 2015. The fund was located in Europe if to be more exact in United Kingdom. Hikma Ventures appeared to be a CVC structure as part of the corporation. The main office of represented VC is situated in the London.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Nebula Genomics, Pillo Health, Biolinq For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Health Care, Therapeutics.
The average startup value when the investment from Hikma Ventures is 50-100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. This Hikma Ventures works on 19 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Hikma Ventures, startups are often financed by Social Capital, Safeguard Scientifics, MentorTech Ventures. The meaningful sponsors for the fund in investment in the same round are Safeguard Scientifics, Social Capital, SR One. In the next rounds fund is usually obtained by Stanley Black & Decker, Social Capital, Samsung Ventures.
We also calculated 2 valuable employees in our database.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 2.56
- Follow on index
- 0.26
- Investments by industry
- Health Care (20)
- Medical (10)
- Medical Device (9)
- Biotechnology (8)
- mHealth (5) Show 31 more
- Investments by region
-
- United States (19)
- United Arab Emirates (1)
- Canada (2)
- Egypt (1)
- Peak activity year
- 2022
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 22M
- Group Appearance index
- 0.91
- Avg. company exit year
- 11
- Avg. multiplicator
- 3.22
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biolinq | 02 Nov 2021 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 100M | United States, California, San Diego |
| Octave Bioscience | 26 Jul 2023 | Biotechnology, Health Care, Health Diagnostics, Medical, Clinical Trials | Early Stage Venture | 32M | United States, California |
| Physio4D | 23 Sep 2016 | Artificial Intelligence, Fitness, Health Care, Wellness, Medical, Computer Vision | Seed | Alberta, Calgary, Canada |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.